FMR LLC - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 52 filers reported holding ORAMED PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.

Quarter-by-quarter ownership
FMR LLC ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,349
-61.5%
900
-67.9%
0.00%
Q1 2023$6,104
-98.7%
2,800
-92.6%
0.00%
Q4 2022$453,363
+85.8%
37,6860.0%0.00%
Q3 2022$244,000
-36.5%
37,686
-55.1%
0.00%
Q2 2022$384,000
-8.1%
83,857
+73.4%
0.00%
Q1 2022$418,00048,3600.00%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
MORGAN JESS S & CO INC 290,501$2,513,0001.83%
Knoll Capital Management, LLC 20,000$173,0000.11%
Private Portfolio Partners LLC 42,250$365,4630.09%
Rossmore Private Capital 40,661$352,0000.06%
OCCUDO QUANTITATIVE STRATEGIES LP 54,233$469,0000.04%
Cubist Systematic Strategies, LLC 241,892$2,092,0000.02%
TWO SIGMA ADVISERS, LP 662,000$5,726,0000.02%
TWO SIGMA INVESTMENTS, LP 550,956$4,766,0000.01%
Jump Financial, LLC 34,800$301,0000.01%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 264,824$2,291,0000.01%
View complete list of ORAMED PHARMACEUTICALS INC shareholders